ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 552 filers reported holding ASTRAZENECA PLC in Q4 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -4.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $25 | +8.7% | 350 | +20.7% | 0.00% | 0.0% |
| Q1 2023 | $23 | -32.4% | 290 | -42.0% | 0.00% | -20.0% |
| Q4 2022 | $34 | -99.9% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $27,000 | -18.2% | 500 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $33,000 | 0.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $33,000 | -5.7% | 500 | -16.7% | 0.01% | 0.0% |
| Q4 2021 | $35,000 | -2.8% | 600 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $36,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $36,000 | +20.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $30,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $30,000 | -50.0% | 600 | -45.5% | 0.01% | -54.5% |
| Q3 2020 | $60,000 | +3.4% | 1,100 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $58,000 | +18.4% | 1,100 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $49,000 | -10.9% | 1,100 | 0.0% | 0.01% | +10.0% |
| Q4 2019 | $55,000 | +12.2% | 1,100 | 0.0% | 0.01% | +11.1% |
| Q3 2019 | $49,000 | +19.5% | 1,100 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $41,000 | -4.7% | 1,100 | 0.0% | 0.01% | +12.5% |
| Q3 2018 | $43,000 | – | 1,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |